Chamberlain MC - Search Results

1

State of the art and perspectives in the treatment of glioblastoma.

Grimm SA, Chamberlain MC. Grimm SA, et al. Among authors: chamberlain mc. CNS Oncol. 2012 Sep;1(1):49-70. doi: 10.2217/cns.12.5. CNS Oncol. 2012. PMID: 25054300 Free PMC article. Review.

2

A phase II study of bevacizumab and erlotinib after radiation and temozolomide in MGMT unmethylated GBM patients.

Raizer JJ, Giglio P, Hu J, Groves M, Merrell R, Conrad C, Phuphanich S, Puduvalli VK, Loghin M, Paleologos N, Yuan Y, Liu D, Rademaker A, Yung WK, Vaillant B, Rudnick J, Chamberlain M, Vick N, Grimm S, Tremont-Lukats IW, De Groot J, Aldape K, Gilbert MR; Brain Tumor Trials Collaborative. Raizer JJ, et al. J Neurooncol. 2016 Jan;126(1):185-192. doi: 10.1007/s11060-015-1958-z. J Neurooncol. 2016. PMID: 26476729 Free PMC article. Clinical Trial.

3

A phase II trial of PTK787/ZK 222584 in recurrent or progressive radiation and surgery refractory meningiomas.

Raizer JJ, Grimm SA, Rademaker A, Chandler JP, Muro K, Helenowski I, Rice L, McCarthy K, Johnston SK, Mrugala MM, Chamberlain M. Raizer JJ, et al. J Neurooncol. 2014 Mar;117(1):93-101. doi: 10.1007/s11060-014-1358-9. Epub 2014 Jan 22. J Neurooncol. 2014. PMID: 24449400 Clinical Trial.

4

A phase 2 trial of verubulin for recurrent glioblastoma: a prospective study by the Brain Tumor Investigational Consortium (BTIC).

Chamberlain MC, Grimm S, Phuphanich S, Recht L, Zhu JZ, Kim L, Rosenfeld S, Fadul CE; Brain Tumor Investigational Consortium (BTIC). Chamberlain MC, et al. J Neurooncol. 2014 Jun;118(2):335-343. doi: 10.1007/s11060-014-1437-y. Epub 2014 Apr 17. J Neurooncol. 2014. PMID: 24740196 Clinical Trial.

5

Bevacizumab and other novel therapies for recurrent oligodendroglial tumors.

Grimm SA, Chamberlain MC. Grimm SA, et al. Among authors: chamberlain mc. CNS Oncol. 2015;4(5):333-9. doi: 10.2217/cns.15.27. Epub 2015 Oct 28. CNS Oncol. 2015. PMID: 26509217 Free PMC article. Review.

6

Anaplastic astrocytoma.

Grimm SA, Chamberlain MC. Grimm SA, et al. Among authors: chamberlain mc. CNS Oncol. 2016 Jul;5(3):145-57. doi: 10.2217/cns-2016-0002. Epub 2016 May 27. CNS Oncol. 2016. PMID: 27230974 Free PMC article. Review.

7

Hodgkin's Lymphoma: A Review of Neurologic Complications.

Grimm S, Chamberlain M. Grimm S, et al. Adv Hematol. 2011;2011:624578. doi: 10.1155/2011/624578. Epub 2010 Oct 11. Adv Hematol. 2011. PMID: 20975772 Free PMC article.

8

A phase 2 trial of single-agent bevacizumab given in an every-3-week schedule for patients with recurrent high-grade gliomas.

Raizer JJ, Grimm S, Chamberlain MC, Nicholas MK, Chandler JP, Muro K, Dubner S, Rademaker AW, Renfrow J, Bredel M. Raizer JJ, et al. Among authors: chamberlain mc. Cancer. 2010 Nov 15;116(22):5297-305. doi: 10.1002/cncr.25462. Cancer. 2010. PMID: 20665891 Free article. Clinical Trial.

9

Brainstem glioma: a review.

Grimm SA, Chamberlain MC. Grimm SA, et al. Among authors: chamberlain mc. Curr Neurol Neurosci Rep. 2013 May;13(5):346. doi: 10.1007/s11910-013-0346-3. Curr Neurol Neurosci Rep. 2013. PMID: 23512689 Review.

10

A multi-institutional phase II trial of bevacizumab for recurrent and refractory meningioma.

Kumthekar P, Grimm SA, Aleman RT, Chamberlain MC, Schiff D, Wen PY, Iwamoto FM, Gursel DB, Reardon DA, Purow B, Kocherginski M, Helenowski I, Raizer JJ. Kumthekar P, et al. Among authors: chamberlain mc. Neurooncol Adv. 2022 Aug 19;4(1):vdac123. doi: 10.1093/noajnl/vdac123. eCollection 2022 Jan-Dec. Neurooncol Adv. 2022. PMID: 36225651 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

383 results

Search Page

Filters